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sclerosis has made possible a wide variety of descriptive
and mechanistic studies. The most widely used model 
is the apolipoprotein E–deficient (apoE–/–) mouse.2,3
Apolipoprotein E deficiency results in a sustained hyper-
cholesterolemia and development of atherosclerotic
lesions, with many features in common with human
plaques.4 A more severe hyperlipidemia and accelerated
lesion development can be achieved if the mice are fed
diets with a fat and cholesterol composition similar to that
of the typical American (Western diet [WD]). Several fac-
tors that retard the progression of atherosclerosis in
apoE–/– mice have been reported, including normaliza-
tion of the plasma lipoprotein profile and elevation of the
plasma levels of high-density lipoprotein.3,5,6 Progression
of early (ie, foam cell) lesions is more sensitive to inter-
vention than advanced intimal lesions (ie, those contain-
ing, in addition to macrophage foam cells, extracellular
lipid deposits, increased matrix, and smooth muscle cells
[SMCs] associated with intimal disorganization, repair,
and thickening).7 For example, in recent studies, adenovi-
ral-mediated gene transfer of human apoE DNA into
apoE–/– mice decreased plasma cholesterol levels and
reduced, by almost a factor of 10, the size of early, foam-
Given the serious adverse consequences of atheroscle-
rotic disease in multiple organs, considerable interest exists
in identifying factors that reduce its severity.1 Most clinical
and animal studies have focused on factors that retard ath-
erosclerosis progression. Although more difficult to
approach experimentally, promoting regression has thera-
peutic potential, not only in primary, but also in secondary
prevention of complications of atherosclerosis (eg, stroke
and myocardial infarction).
The development of mouse models of human athero-
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Objective: Regression of atherosclerotic lesions is an important goal. No extensive experimental evidence shows that it
can be achieved for advanced lesions. To study this, we developed a model to maintain a long-term change in the plasma
lipoprotein environment of advanced arterial lesions of hyperlipidemic (apolipoprotein E [apoE]–deficient) mice.
Methods: The apoE-deficient mice (plasma total cholesterol of 1334 ± 219 [± SEM] mg/dL) on a typical Western diet
for 38 weeks had advanced atherosclerotic lesions (ie, beyond the macrophage foam cell stage) throughout the arterial
tree. Lesion-containing thoracic aortas were transplanted (replacing a segment of abdominal aorta) into either apoE-
deficient or wild-type (WT) (total cholesterol of 86 ± 10 mg/dL) recipients. Grafts were harvested after 9 weeks.
Results: Compared with pretransplant lesions (area = 0.0892 ± 0.0179 mm2), lesion size tended to increase in apoE-
deficient to apoE-deficient grafts (0.2411 ± 0.0636 mm2; P = .06), whereas a significant reduction was seen in
apoE–deficient to WT grafts (0.0214 ± 0.0049 mm2; P < .001). Also, foam cells were absent in apoE-deficient to WT
grafts, but abundant in pretransplant lesions and apoE-deficient to apoE-deficient grafts. Grafts were evaluated non-
invasively in vivo with magnetic resonance imaging, and wall thickening was detected in the apoE-deficient to apoE-
deficient group.
Conclusions: Nearly complete regression of advanced atherosclerotic lesions can be achieved with sustained normaliza-
tion of the plasma lipoprotein profile. Syngeneic arterial transplantation in mice is a novel and valuable model system
for atherosclerosis research; and magnetic resonance imaging can detect differences in characteristics in lesions under-
going regression. (J Vasc Surg 2001;34:541-7)
cell lesions6,8; however, effects on the size of more
advanced lesions were relatively modest (< 20%).6
In this article we describe a mouse model for athero-
sclerosis research in which the lipoprotein environment of
a lesion of any complexity can be changed rapidly and sus-
tained indefinitely. This lipid-profile manipulation is
achieved with microsurgical arterial transplantation tech-
niques and allows effects on lesion characteristics to be
studied over a longer period than currently possible with
gene transfer approaches. This model demonstrates that
advanced, complex plaques of apoE–/– mice can undergo
dramatic remodeling and regression after only 2 months
of exposure to the normolipidemic plasma environment of
the wild-type (WT) mouse. In addition, high-resolution
magnetic resonance (MR) imaging noninvasively detected
changes in lesion characteristics in vivo, thereby confirm-
ing the possibility of monitoring plaque characteristics that
change over time in the intact animal.
METHODS
Animals, diets, and experimental design. The
apoE–/– and WT mice in the C57BL/6 background
(Jackson Laboratories, Bar Harbor, Me) were used. This
study was approved by the Institutional Animal Care and
Use Committee, and the animal care complied with the
Guide for the Care and Use of Laboratory Animals,
Institute of Laboratory Animal Resources, Commission
on Life Sciences, National Research Council, Washington:
National Academy Press, 1996.
In pilot studies, syngeneic aortic transplantation was
performed among WT C57BL/6 mice to assess adverse
sequelae, such as transplant arteriopathy or poor weight
gain. No such sequelae were observed for up to 10
months. For the regression studies, apoE–/– mice (n = 18)
were weaned at 4 weeks of age onto the WD (21% fat,
0.15% cholesterol wt/wt3; Dyets Inc, Bethlehem, Pa) and
fed this diet for 9 months. These apoE–/– mice were
divided into two groups: one group of 12 served as donors
of thoracic aortic segments, and one group of six was eu-
thanized to obtain thoracic aortas for pretransplant (base-
line) analyses. At the time of transplantation, all donors had
severe hyperlipidemia (total cholesterol [TC] = 1334 ± 19
mg/dL, n = 9) and advanced atherosclerotic lesions (ie,
beyond the macrophage foam cell stage; see later) diffusely
distributed in the thoracic aorta. The recipients (28 weeks
of age) of the aortic segments were either apoE–/– (n = 4)
or WT (n = 8) mice maintained on a standard chow diet
(4.5% fat) before and after transplantation. The apoE–/–
recipients served as a control for the transplantation proce-
dure (eg, ischemia-reperfusion injury), with the pretrans-
plant samples serving as the reference point of comparison
to assess progression or regression.
After 2 months, the recipients were euthanized and
graft segments analyzed. Three days before euthanasia, a
subset of mice randomly chosen was subjected to in vivo
MR imaging so that changes could be explored noninva-
sively in the lesions in the grafts associated with the type of
recipient (WT or apoE–/–).
Transplantation procedures. Transplantation of a
segment of donor thoracic aorta into a recipient infrarenal
position was performed.9 Mice were anesthetized with
pentobarbital sodium (60 mg/kg per body weight,
Nembutal7; Abbott Laboratories, North Chicago, Ill).
Donor aortas were flushed with heparinized saline, and a
4-mm segment was taken from the midportion between
the left subclavian artery and diaphragm. The infrarenal
aorta of recipients was exposed, clamped proximally and
distally, and transected. The donor aortic segment was
then inserted as a tube graft by microsurgical anastomosis.
(For details, see the appendix, online only.)
Measurement of plasma lipids and lipoproteins.
TC was determined in plasma samples with a commercial
kit (Boehringer-Mannheim, Mannheim, Germany).
Histology, immunohistochemistry, and morphom-
etry. All specimens were analyzed by an investigator
blinded to their source (pretransplant, apoE–/– to WT
isograft, or apoE–/– to apoE–/– isograft). Mice under-
went perfusion fixation with 4% paraformaldehyde in
phosphate-buffered saline as described.10 Thoracic aortas
(pretransplant group) or abdominal aortas containing the
grafts (transplant group) were removed en bloc with the
posterior bony structures, fixed in 4% paraformaldehyde
for 24 hours, decalcified overnight, sectioned transversely,
and embedded in paraffin. Transplanted segments were
identified by visualization of proximal and distal anasto-
motic nylon sutures. The segments of thoracic aorta at
donor sites and engrafted infrarenal segments were
divided at their midportion, and 5-µm thick sections were
obtained for staining with hematoxylin and eosin (H&E)
and a combined Masson’s trichrome elastic stains. Lesions
were classified by histomorphologic criteria: type I, dis-
playing scattered macrophage foam cells; type II, contain-
ing layers of foam cells and lipid-laden SMCs; type III,
containing scattered collections of extracellular lipid and
disrupted SMC architecture; type IV, having a larger, con-
fluent, and more disruptive core of extracellular lipid; type
V, containing thick layers of fibrous connective tissue; type
Vb, largely calcified; type Vc, consisting primarily of con-
nective tissue, with minimal accumulation of lipid or cal-
cium; and type VI, displaying fissures, hematoma, and
thrombus.7
For immunohistochemistry, sequential sections were
stained for α-actin (alkaline-phosphatase–conjugated mon-
oclonal anti–α-smooth muscle actin; Sigma, St Louis, Mo;
1:100 final titer); macrophages (MOMA-2; rat antimouse
macrophages-monocytes; Serotec, Kindlington, United
Kingdom; 2 µg/mL); vascular cell adhesion molecule–1
(VCAM-1; rat antimouse CD106/VCAM-1; Southern
Biotechnology Associates, Birmingham, Ala; 10 µg/mL);
intracellular adhesion molecule–1 (ICAM-1; rat antimouse
ICAM-1; Seikagaku, Tokyo, Japan; 3 µg/mL); factor
VIII–related antigen (to identify endothelial cells; rabbit
antihuman von Willebrand’s factor; Dako, Glostrup,
Denmark; 0.57 µg/mL); and acylcoenzyme A cholesterol
acyltransferase (ACAT; rabbit anti-ACAT peptide; gift of
Drs Hongxing Wang [Mount Sinai School of Medicine,
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New York, NY] and Ira Tabas [Columbia University, New
York, NY]). The immunostaining protocol is described
elsewhere.10 Negative controls were obtained by substitu-
tion of the primary antibody with an irrelevant antibody.
When mouse monoclonal reagents were used, control sec-
tions were also stained with an immunoglobulin G isotype
to assess specificity of the secondary antibody.
For computerized morphometry, two sections from
each lesion were analyzed. Cross-sectional areas measured
were luminal area, area bounded by internal elastic lamina,
and area bounded by external elastic lamina. Lesion area
was calculated as internal elastic lamina area minus luminal
area and represents the average of two values expressed as
square millimeter per section. Macrophage content was
determined by measuring the area of the lesion positively
stained with MOMA-2.
MR imaging. Four mice, two from each recipient
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group, underwent MR imaging, as described previously.11
In vivo MR microscopy of the abdominal aorta was per-
formed with a 9.4-T, 89-mm vertical bore system, operat-
ing at a proton frequency of 400 MHz, and equipped with
a 50-mm internal diameter gradient insert. Eight trans-
verse slices, 1 mm thick, with a center-to-center gap of 2
mm, were acquired from the abdominal aorta with proton
density-weighted sequence with a time of repetition/time
of echo of 2000/13 ms, respectively. A 256 × 256-matrix
spin-echo sequence was used for two-dimensional axial
imaging with a pixel size of 117 × 117 × 1000 µm3. The
total imaging time was 17 minutes for each proton den-
sity-weighted sequence. The MR images were correlated
Fig 1. Histologic characteristics of atherosclerotic lesions in
apoE–/– mouse aortas before and after transplantation. Thoracic
aortic segments that contained advanced atherosclerotic lesions
were transplanted into either WT (normocholesterolemic) 
or apoE–/– (hypercholesterolemic) syngeneic recipients. 
A, Representative histologic cross sections of aortas before (pre-
transplant) and 2 months after transplantation (top row, H&E
staining; bottom row, MOMA-2 immunostaining; original magni-
fication, × 40). Pretransplant lesions of apoE–/– mice have thin
cap, are rich in macrophage foam cells, and contain extracellular
lipid core. A larger, more advanced lesion is seen in section taken
from graft in apoE–/– recipient. In contrast to these two lesions,
lesion in the graft in WT recipient is remarkable for lack of foam
cell–containing intima and thinner medial layer, indicating both
regression and remodeling compared with pretransplant state. 
B, Morphometric analysis of neointima area and macrophage
content (assessed by area of MOMA-2 immunostaining) in
lesions from pretransplant thoracic aortic segments and grafts in
apoE–/– and WT recipients. Data are displayed as mean ± SEM.
A
B
with histopathologic cross sections by means of anatomic
landmarks.
Statistical analysis. Numerical data are expressed as
means ± SEM and were analyzed with the unpaired, 2-
tailed Student t test, assuming unequal variance. P values
less than .05 were considered significant.
RESULTS
Heterotopic, syngeneic aortic transplantation was first
evaluated in WT mice of the inbred, C57BL/6 strain.
Approximately 80% survival was obtained, as reported
originally with this procedure (in that report, allogeneic
transplants were used to study transplant vasculopathy).9
Recipient mice were euthanized 2, 3, 6, and 10 months
after transplantation (n = 2, for each time point). In con-
trast to the original report,9 as expected, a histologic
examination of the syngeneic grafts showed no evidence of
transplant arteriopathy, such as lymphocytic infiltration,
and all recipients grew normally and appeared healthy.
After weaning, 18 apoE–/– mice on the C57BL/6
background were fed a WD for 9 months, to allow the for-
mation of advanced, complex atherosclerotic lesions (ie,
lesions containing foam cells, SMCs, extracellular matrix,
and lipid deposits). To assess the size and stage of lesions
before transplantation, we euthanized six mice and graded
their thoracic aorta lesions according to histologic compo-
sition and structure.7 The average grade was 3.5 (a grade 
≤ 2 represents fatty streaks and foam cell lesions, ie, “early”
lesions), consistent with the complexity of the lesions (Fig
1, A). Segments of thoracic aorta containing such lesions
were taken from the remaining mice and transplanted to
the infrarenal aorta of either apoE–/– (n = 4) or WT (n =
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Fig 2. Immunohistochemical analysis of apoE–/– mouse atherosclerotic lesions before and after transplantation. Lesional sections from:
top row, pretransplant lesion from thoracic aorta. Note abundant immunostaining for functional foam cell marker, ACAT (brown), adhe-
sion molecules (also brown), and presence of SMC-marker α-actin (red) within lesion. Middle row, Graft from WT recipient. Compared
with top and bottom rows, note thinner intima and media, and reduced immunostaining for α-actin, ACAT, and VCAM-1, but not
endothelial ICAM-1. Bottom row, Graft from apoE–/– recipient. Note similarities to pretransplant lesion, with presence of multiple cho-
lesterol crystals and gross disruption of tissue architecture from continued progression. Original magnification, ×100. 
8) recipients. Recipient mice were fed standard chow diets,
which maintained plasma lipoproteins at either normal
(WT mice; TC: 86 ± 10 mg/dL) or moderately hyperlipi-
demic (apoE–/– mice; TC: 558 ± 26 mg/dL) levels. (One
apoE–/– and two WT recipients died in the early postop-
erative period; the mortality rate was 25%.)
The engrafted segments were removed for analysis 2
months after transplantation. Lesion size and the area of
immunostaining for specific proteins were quantified.
Remodeling (ie, a change in lesion composition) and
regression (ie, a change in lesion size) were obvious in grafts
transplanted into WT recipients (Fig 1, A, top row).
Compared with the pretransplant lesion area of 0.0892 ±
0.0179 mm2 (Fig 1, B), lesions significantly (P = .003) pro-
gressed in the setting of hyperlipidemia to a cross-
sectional area of 0.2411 ± 0.0636 mm2, in the apoE–/– to
apoE–/– grafts. In contrast, in the setting of normolipi-
demia, the lesion area was reduced dramatically (P = .0001)
to 0.0214 ± 0.0049 mm2 in the apoE–/– to WT grafts.
Furthermore, the grafts in the WT recipients were devoid of
macrophage foam cells, which was revealed by either mor-
phologic inspection (Fig 1, A, top row) or immunostaining
analysis (Fig 1, A, bottom row). Consistent with this finding
are the quantitative changes in the area of monocyte-
macrophage immunostaining, which are summarized in 
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Fig 1, B. Note the remarkable decrease (P < .001) from the
pretransplant value of 0.0253 ± 0.0055 mm2 (22% of lesion
area) to 0.0002 ± 0.0001 mm2 (1% of lesion area) in the
apoE–/– to WT grafts. In contrast, apoE–/– to apoE–/–
grafts had increased MOMA-2 staining, to 0.0510 ±
0.0157 mm2; however, the percentage of lesion area posi-
tively stained (21%) remained similar to the pretransplant
value (22%).
For further assessment of lesion remodeling,
immunostaining was performed for α-actin, a marker for
SMC; ACAT, the intracellular enzyme that converts cho-
lesterol to cholesteryl ester (ie, a functional marker of
foam cells); and the adhesion molecules, ICAM-1 and
VCAM-1. Representative results are shown in Fig 2. The
presence of the SMC marker α-actin in the expanded
neointima confirmed the complexity of the lesions in the
pretransplant aorta and apoE–/– to apoE–/– graft (ie,
that they had progressed past the macrophage foam cell
stage). In contrast, the lesion from the WT recipient is
notable for the decreased areas of α-actin immunostain-
ing of intima and media. The results for the media prob-
ably indicate a change in SMC phenotype that is part of
the wide-scale remodeling process that must occur dur-
ing the 2 months the lesions were in the normolipidemic
environment.
Fig 3. MR imaging of mouse aortic transplants correlates with graft wall thickness. Thoracic aortic seg-
ments were transplanted into infrarenal portion of aorta as interposition grafts. MR images of grafts from
WT recipient (top row) and apoE–/– recipient (bottom row) were obtained in vivo 2 months after trans-
plantation. Mice were then euthanized and grafts taken for gross (left panel) and histologic (middle panel;
H&E stain; ×40) examination. Note difference in wall thickness apparent at gross and histologic levels is
paralleled by corresponding change in MR image (aortic grafts are indicated by arrows in right panel).
ACAT immunostaining (Fig 2) was extensive in the
pretransplant and apoE–/– to apoE–/– lesions (top and
bottom rows, respectively), but absent from the apoE–/– to
WT lesion (middle row), which was consistent with the
results for MOMA-2. Note the overlapping immunostain-
ing patterns of ACAT and α-actin, implying that foam
cells could be of macrophage or SMC origin.
Immunostaining for two principal adhesion mole-
cules, ICAM-1 and VCAM-1, was assessed after confirma-
tion with factor-VIII–related antigen immunostaining that
intact endothelium was present in each sample (data not
shown). As shown in the representative sections displayed
in Fig 2 (panels 3 and 4), expression of ICAM-1 was com-
parable in the sections of all groups. In contrast to the
results for ICAM-1, despite no obvious difference in
VCAM-1 expression between pretransplant and apoE–/–
to apoE–/– lesions, VCAM-1 was absent in the sections
from the apoE–/– to WT grafts (Fig 2).
We tested whether in vivo MR could distinguish
between the grafts in the two types of recipient mice. Fig
3 shows representative gross, histologic, and MR images
of apoE–/– to WT grafts (top row) and apoE–/– to
apoE–/– grafts (bottom row). The MR images were
obtained 1 day before the mice underwent euthanasia.
Note that the difference in wall thickness between the two
lesions, apparent by gross or histologic examination, is
paralleled by a corresponding change in the wall thickness
detected with MR imaging.
DISCUSSION
From the results obtained in these experiments, we con-
clude that (1) regression and remodeling of atherosclerotic
lesions that progressed past the macrophage foam cell stage
in the apoE–/– mouse model can be achieved by sustained
normalization of the plasma lipoprotein profile; (2) mag-
netic imaging resonance can detect differences in character-
istics in lesions undergoing regression; and (3) syngeneic
arterial transplantation in mice can be useful as a model sys-
tem to study mechanisms regulating changes in plaques.
Our findings should be considered in the context of
the current concepts of plaque regression and remodeling
and the recent animal models used to study these
processes.12,13 From studies with primarily cholesterol-fed
rabbits, early foam cell aortic lesions have been shown to
be highly reversible to a prelesional state whether addi-
tional high-density lipoprotein was provided or plasma
lipid levels were lowered.14-16 A predominant assumption
has been that with similar adjustments of the lipoprotein
profile, advanced, complex lesions may not be regressed
significantly in size, but are more likely to undergo remod-
eling, in which the lipid core decreases, macrophage con-
tent decreases, and fibrous cap thickens.1,14,17
Relative to the pretransplant lesions, those in the
apoE–/– to apoE–/– group were larger, but qualitatively
similar, whereas those in the apoE–/– to WT group were
different both quantitatively and qualitatively. Given that
the pretransplant lesions develop over a 9-month period,
increased lesion size in the apoE–/– recipient detected
after only 2 months from transplantation suggest acceler-
ated progression. The mechanism for this phenomenon
could not be defined in the current study; however, it has
been noted that the progression of lesions in apoE–/–
mice is nonlinear, with an accelerated rate in animals from
28 to 40 weeks of age (ie, roughly the age of recipients
during the posttransplantation period in our study).18
The results in the apoE–/– to WT grafts demonstrate
the remarkable capacity of a postmacrophage foam cell
lesion to be remodeled and regressed. Such changes have
been observed only for early, foam cell lesions in apoE–/–
mice when TC was transiently lowered with adenoviral
approaches19; our obtaining similar results for more
advanced lesions clearly reflects the ability of the syngeneic
transplantation model to sustain a new and stable lipopro-
tein environment indefinitely. By current understanding,
the smaller size and absolute and relative decreases in
macrophage content of the lesions in the apoE–/– to WT
grafts are expected to be plaque-stabilizing effects.12,14
Upregulation of cell adhesion molecules, which pro-
motes the recruitment of mononuclear cells to the vascu-
lar wall, has been demonstrated previously in lesions of
apoE–/– mice.4 The expression of ICAM-1 in endothe-
lium, independent of atherosclerosis, has been reported
recently4,13 and is consistent with our recent results in
healthy mice.10 In contrast, VCAM-1 expression appears
to be more labile; not typically present in normal
endothelium, its expression has been shown to be an early
event in lesion formation and further upregulated as
lesions progress in apoE–/– mice.4 Our results suggest
that VCAM-1 expression can become downregulated
under conditions that promote lesion regression and
remodeling.
In long-term atherosclerosis studies, it would be con-
siderably advantageous to follow the changes in lesion
characteristics over time noninvasively, without the inter-
current sacrificing of animals for monitoring.20 The capa-
bility of MR to image lesions in the abdominal aorta of
living apoE–/– mice has been shown.11 Although not an
end point in the current study, the MR images obtained
suggest MR may be sufficiently sensitive to serially moni-
tor over time the progression or regression of lesions non-
invasively in mouse models of atherosclerosis after
metabolic, genetic, and pharmacologic interventions.
In summary, this transplantation model has demon-
strated that advanced atherosclerotic lesions in apoE–/–
mice have properties more dynamic than predicted,
according to studies in human beings and other animals.17
It should now be possible with this model to undertake a
number of studies aimed at discovering or better defining
systemic antiatherosclerosis factors and their mechanisms.
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tic stumps allows appropriate space for insertion of the
graft without tension or kinking. The donor segment (4
mm in length) is sutured as an interposition graft.
Proximal and distal end-to-end anastomoses are con-
structed with interrupted sutures of 11-0 nylon monofila-
ment (US Surgical, Norwalk, Conn).
Animals are kept on a warming pad until fully recov-
ered from anesthesia. They are monitored clinically each
hour for the first 4 hours and then once daily.
Postoperative analgesia is provided with acetaminophen
(Tylenol), orally, diluted in the drinking water.
Complications of this procedure include thrombosis
of the aorta, evisceration, and bleeding. Aortic thrombo-
sis consistently results in lower extremity paralysis, usually
followed by rapid deterioration of general condition and
death within 24 to 48 hours. Signs of distress, such as
paralysis of lower extremities, labored respiration,
decreased mobility, or avoidance of food, prompt immedi-
ate euthanasia.
The perioperative mortality rate for this procedure is
expected to be at least 20%.1 In the current study, the mor-
tality rate was 25%. Fashioning of anastomosis is challeng-
ing because of the small diameter of the mouse abdominal
aorta (< 0.8 mm). Even under adequate magnification, the
surgery requires highly skilled maneuvers.
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The transplantation model used in the current study
was adapted from the original description by Koulack et al.1
Procedures are carried out with the aid of an operative
microscope (Carl Zeiss, Thornwood, NY), with 20 to 40×
magnifications.
Donor operation. A midline laparotomy is made and
extended through bilateral parasternal thoracotomies. The
sternum is elevated, exposing the mediastinum. Heparin
solution (3 mL, 100 U/mL; Hep-Lock, Elkins-Sinn,
Cherry Hill, NJ) is injected into the left ventricle to flush
the aorta. A 4-mm long segment of thoracic aorta (from
its midportion, between left subclavian artery and
diaphragm) is harvested. Periaortic fat is excised, and
intercostal arteries are transected at a distance (1-2 mm)
from their take off. This maneuver leads to retraction and
contraction of the arterial stumps, preventing bleeding
and avoiding the use of cautery or sutures for hemostasis.
Recipient operation. After adequate anesthesia, the
animal’s paws are fixed to the table, and a midline abdom-
inal incision is made. The intestines are retracted with
moist sponges, exposing the retroperitoneum. The mid-
portion of the infrarenal aorta is dissected free from the
vena cava and surrounding tissues and isolated between
minivessel clamps (Accurate Surgical and Scientific
Instruments, Westbury, NY). Hemostasis can be accom-
plished with a Malls Bipolar Coagulator (Codman &
Schurtleff, Randolph, Mass). The abdominal aorta is tran-
sected between the clamps, and a 1-mm long segment is
excised. This excision combined with retraction of the aor-
